This compound is a pharmaceutical intermediate specifically designed for the synthesis of adenosine analogs. It features a purine ring system with an iodine substituent and multiple polar functional groups, making it a key building block in nucleoside analog manufacturing.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 141018-29-3
NECA
adenosine receptor agonist
(2S,3S,4R,5R)-2-[(2-fluorophenyl)sulfanylmethyl]-5-[6-[[(1R,2R)-2-hydroxycyclopentyl]amino]purin-9-yl]oxolane-3,4-diol
Pharmaceutical intermediate for adenosine analogs
8-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one
pharmaceutical intermediate
TERT-BUTYL N-[(1S)-1-(BENZYLCARBAMOYL)-2-HYDROXYETHYL]CARBAMATE
peptide synthesis intermediate
(R)-Tetrahydropapaverine N-acetyl-L-leucinate
pharmaceutical raw material
(1S,4R)-4-[(2,5-Diamino-6-chloro-4-pyrimidinyl)amino]-2-cyclopentene-1-methanol
Pharmaceutical intermediate for abacavir
(2S,3S,4R,5R)-5-(6-amino-2-iodopurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide
YEBHQRSEUJCFMN-QMWPFBOUSA-N
CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)I)N)O)O